Stockholm is bracing for the Chemistry Nobel. The Royal Swedish Academy of Sciences will reveal the winner on October 7, 2026, at 11:45 CEST (09:45 GMT). That’s the official time, straight from the Nobel Prize’s own educational materials. The Chemistry Nobel is not decided by the Karolinska Institute. Instead, the Royal Swedish Academy of Sciences makes the call. Their process stands apart, as detailed on the official Nobel Prize site.
Gene editing is at the center of the buzz. David Liu, a US chemist and biologist, is in the spotlight for his work on editing DNA in living cells. He developed base editing, which swaps out single DNA bases without cutting both strands. He also created prime editing, a tool that can insert, delete, or replace genetic code with more precision than classic CRISPR. These tools let scientists rewrite DNA with accuracy that was once out of reach. Many see this as a leap for research and medicine. Swedish public broadcaster Sveriges Radio’s science editor Lars Brostrom has also pointed to British chemists Shankar Balasubramanian and David Klenerman. Their advances in next-generation DNA sequencing have changed genomics and personalized medicine.
The 2026 Nobel Prize in Chemistry announcement was scheduled for October 7 at 11:45 CEST (09:45 GMT), with the Royal Swedish Academy of Sciences responsible for selecting the laureate.
Weight loss drugs and sleep molecules under the spotlight
GLP-1 research is another top contender. GLP-1 is a hormone that controls appetite and blood sugar. It’s the science behind blockbuster drugs like Wegovy and Mounjaro. These drugs have changed the pharmaceutical market. The 2026 Nobel in Physiology or Medicine went to neurobiologists, not GLP-1 researchers. Still, GLP-1 work is seen as a strong Chemistry candidate. Canadian endocrinologist Daniel Drucker, Danish physician Jens Juul Holst, and Yugoslav-born US chemist Svetlana Mojsov are often named for their roles. They helped discover GLP-1 and turn it into a therapy. Clarivate, a data analytics firm, has flagged GLP-1 as a top pick, showing its impact in science and business.
Sleep research is also in the mix. French-born Emmanuel Mignot and Japanese-American Masashi Yanagisawa are known for their work on orexin, a neurotransmitter that controls sleep and wake cycles. Spanish-American scientist Luis de Lecea, who helped discover the orexin system, could share the honor. This research matters for disorders like narcolepsy and insomnia.
GLP-1 did not receive the 2026 Nobel Prize in Physiology or Medicine, which was instead awarded to neurobiologists, but experts such as Clarivate analyst David Pendlebury have suggested that GLP-1 research could be recognized in the Chemistry category.
Surface chemistry and electron transfer research in the mix
Not all eyes are on gene editing and GLP-1. Self-assembled monolayers (SAMs) are drawing attention too. US chemists David Allara and Ralph Nuzzo, along with Israeli chemist Jacob Sagiv, have pushed forward the use of molecular coatings to change surface properties. This technique is now key in materials science and nanotech. US scientists Harry Gray and Jay Winkler have also been recognized for their work on electron transfer in proteins. Their research has deepened our understanding of basic biochemistry.
Other names keep coming up. German-born Swiss chemist Michael Grätzel is known for solar cell breakthroughs. French battery expert Jean-Marie Tarascon, Taiwanese-American biochemist Chi-Huey Wong for work on carbohydrates and glycoproteins, and US chemical engineer Robert Langer for drug delivery and tissue engineering are all in the conversation.
Nobel season and the broader scientific context
This year’s Chemistry Nobel follows the Physics prize, which went to Belgian physicist Francis Halzen for the IceCube Neutrino Observatory and the discovery of high-energy neutrinos from space. The Literature and Peace prizes are next. The Economics Nobel will close out the 2026 season on October 12. Each Nobel comes with a diploma, a gold medal, and a share of 12 million Swedish kronor (about $1.2 million).
Gene editing and sequencing are not just trends. They are driving big projects, like the NIH single cell brain atlas reported earlier, which has changed how scientists see molecular neuroscience. The lines between molecular biology, genomics, and applied research are blurring. This is the new engine of science. As the Nobel committee makes its choice, the real story is the steady march of new methods. These tools are changing both science and biotech business. The 2026 Chemistry Nobel will do more than honor a person. It will show which fields now set the pace for discovery.
